EP1271239A2 - Anordnung zur Portalbilderzeugung mit asymmetrischen Verstärkerschirmen und Verfahren zur Verwendung - Google Patents
Anordnung zur Portalbilderzeugung mit asymmetrischen Verstärkerschirmen und Verfahren zur Verwendung Download PDFInfo
- Publication number
- EP1271239A2 EP1271239A2 EP02077431A EP02077431A EP1271239A2 EP 1271239 A2 EP1271239 A2 EP 1271239A2 EP 02077431 A EP02077431 A EP 02077431A EP 02077431 A EP02077431 A EP 02077431A EP 1271239 A2 EP1271239 A2 EP 1271239A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- silver halide
- radiographic
- film
- imaging assembly
- films
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000003384 imaging method Methods 0.000 title claims abstract description 70
- 238000000034 method Methods 0.000 title claims description 15
- -1 silver halide Chemical class 0.000 claims abstract description 152
- 229910052709 silver Inorganic materials 0.000 claims abstract description 143
- 239000004332 silver Substances 0.000 claims abstract description 143
- 239000000839 emulsion Substances 0.000 claims description 85
- 238000012545 processing Methods 0.000 claims description 63
- 239000000203 mixture Substances 0.000 claims description 50
- 229910052751 metal Inorganic materials 0.000 claims description 22
- 239000002184 metal Substances 0.000 claims description 22
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 15
- 239000000084 colloidal system Substances 0.000 claims description 10
- 230000001235 sensitizing effect Effects 0.000 claims description 9
- 230000003595 spectral effect Effects 0.000 claims description 9
- 239000004848 polyfunctional curative Substances 0.000 claims description 8
- 229920000642 polymer Polymers 0.000 claims description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 5
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 239000010410 layer Substances 0.000 description 78
- 108010010803 Gelatin Proteins 0.000 description 28
- 229920000159 gelatin Polymers 0.000 description 28
- 239000008273 gelatin Substances 0.000 description 28
- 235000019322 gelatine Nutrition 0.000 description 28
- 235000011852 gelatine desserts Nutrition 0.000 description 28
- 239000000975 dye Substances 0.000 description 23
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 20
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 18
- 238000009472 formulation Methods 0.000 description 17
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 16
- 229910052761 rare earth metal Inorganic materials 0.000 description 15
- 238000002560 therapeutic procedure Methods 0.000 description 15
- 238000011160 research Methods 0.000 description 14
- 239000011133 lead Substances 0.000 description 13
- 230000005855 radiation Effects 0.000 description 13
- 230000000712 assembly Effects 0.000 description 12
- 238000000429 assembly Methods 0.000 description 12
- 239000011229 interlayer Substances 0.000 description 12
- 150000002910 rare earth metals Chemical class 0.000 description 12
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 11
- 239000002019 doping agent Substances 0.000 description 11
- 238000001959 radiotherapy Methods 0.000 description 11
- 238000001035 drying Methods 0.000 description 10
- 230000004807 localization Effects 0.000 description 10
- 239000011230 binding agent Substances 0.000 description 9
- 229920002401 polyacrylamide Polymers 0.000 description 9
- 230000001681 protective effect Effects 0.000 description 9
- 239000010948 rhodium Substances 0.000 description 9
- 229910052771 Terbium Inorganic materials 0.000 description 8
- 239000005018 casein Substances 0.000 description 8
- 235000021240 caseins Nutrition 0.000 description 8
- OIDPCXKPHYRNKH-UHFFFAOYSA-J chrome alum Chemical compound [K]OS(=O)(=O)O[Cr]1OS(=O)(=O)O1 OIDPCXKPHYRNKH-UHFFFAOYSA-J 0.000 description 8
- 239000008119 colloidal silica Substances 0.000 description 8
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 239000010949 copper Substances 0.000 description 7
- 229910052802 copper Inorganic materials 0.000 description 7
- 230000009977 dual effect Effects 0.000 description 7
- 239000002245 particle Substances 0.000 description 7
- 229910052703 rhodium Inorganic materials 0.000 description 7
- RZILCCPWPBTYDO-UHFFFAOYSA-N fluometuron Chemical compound CN(C)C(=O)NC1=CC=CC(C(F)(F)F)=C1 RZILCCPWPBTYDO-UHFFFAOYSA-N 0.000 description 6
- 150000004820 halides Chemical class 0.000 description 6
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 6
- 150000002739 metals Chemical class 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 238000002601 radiography Methods 0.000 description 6
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 229910052717 sulfur Inorganic materials 0.000 description 6
- 238000012795 verification Methods 0.000 description 6
- 229910052693 Europium Inorganic materials 0.000 description 5
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 5
- 206010070834 Sensitisation Diseases 0.000 description 5
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 5
- 210000003484 anatomy Anatomy 0.000 description 5
- 239000000314 lubricant Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000008313 sensitization Effects 0.000 description 5
- GZCRRIHWUXGPOV-UHFFFAOYSA-N terbium atom Chemical compound [Tb] GZCRRIHWUXGPOV-UHFFFAOYSA-N 0.000 description 5
- CWGBFIRHYJNILV-UHFFFAOYSA-N (1,4-diphenyl-1,2,4-triazol-4-ium-3-yl)-phenylazanide Chemical compound C=1C=CC=CC=1[N-]C1=NN(C=2C=CC=CC=2)C=[N+]1C1=CC=CC=C1 CWGBFIRHYJNILV-UHFFFAOYSA-N 0.000 description 4
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 4
- 206010073306 Exposure to radiation Diseases 0.000 description 4
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 4
- 229910052765 Lutetium Inorganic materials 0.000 description 4
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 150000001342 alkaline earth metals Chemical class 0.000 description 4
- 239000011324 bead Substances 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052798 chalcogen Inorganic materials 0.000 description 4
- 150000001787 chalcogens Chemical class 0.000 description 4
- HBGZHONGRRAFMI-UHFFFAOYSA-N chembl1507346 Chemical compound N1=C(C)C=C(O)N2N=C(C(O)=O)N=C21 HBGZHONGRRAFMI-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- OHSVLFRHMCKCQY-UHFFFAOYSA-N lutetium atom Chemical compound [Lu] OHSVLFRHMCKCQY-UHFFFAOYSA-N 0.000 description 4
- SCWKACOBHZIKDI-UHFFFAOYSA-N n-[3-(5-sulfanylidene-2h-tetrazol-1-yl)phenyl]acetamide Chemical compound CC(=O)NC1=CC=CC(N2C(N=NN2)=S)=C1 SCWKACOBHZIKDI-UHFFFAOYSA-N 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000011593 sulfur Substances 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 239000010698 whale oil Substances 0.000 description 4
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 229910052688 Gadolinium Inorganic materials 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 239000010955 niobium Substances 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 229920002635 polyurethane Polymers 0.000 description 3
- 239000004814 polyurethane Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 229910052715 tantalum Inorganic materials 0.000 description 3
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- VDMJCVUEUHKGOY-JXMROGBWSA-N (1e)-4-fluoro-n-hydroxybenzenecarboximidoyl chloride Chemical compound O\N=C(\Cl)C1=CC=C(F)C=C1 VDMJCVUEUHKGOY-JXMROGBWSA-N 0.000 description 2
- LRUDIIUSNGCQKF-UHFFFAOYSA-N 5-methyl-1H-benzotriazole Chemical compound C1=C(C)C=CC2=NNN=C21 LRUDIIUSNGCQKF-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 229910052684 Cerium Inorganic materials 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 2
- 229910052772 Samarium Inorganic materials 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229910004369 ThO2 Inorganic materials 0.000 description 2
- 229910052775 Thulium Inorganic materials 0.000 description 2
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 229910001615 alkaline earth metal halide Inorganic materials 0.000 description 2
- 150000001336 alkenes Chemical class 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- SMCGVHCVEHSGLL-UHFFFAOYSA-N carbamimidoyl carbamimidate Chemical class NC(=N)OC(N)=N SMCGVHCVEHSGLL-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000022534 cell killing Effects 0.000 description 2
- GWXLDORMOJMVQZ-UHFFFAOYSA-N cerium Chemical compound [Ce] GWXLDORMOJMVQZ-UHFFFAOYSA-N 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000010304 firing Methods 0.000 description 2
- YBMRDBCBODYGJE-UHFFFAOYSA-N germanium dioxide Chemical compound O=[Ge]=O YBMRDBCBODYGJE-UHFFFAOYSA-N 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 229910052746 lanthanum Inorganic materials 0.000 description 2
- FZLIPJUXYLNCLC-UHFFFAOYSA-N lanthanum atom Chemical compound [La] FZLIPJUXYLNCLC-UHFFFAOYSA-N 0.000 description 2
- 238000009607 mammography Methods 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- DZVCFNFOPIZQKX-LTHRDKTGSA-M merocyanine Chemical compound [Na+].O=C1N(CCCC)C(=O)N(CCCC)C(=O)C1=C\C=C\C=C/1N(CCCS([O-])(=O)=O)C2=CC=CC=C2O\1 DZVCFNFOPIZQKX-LTHRDKTGSA-M 0.000 description 2
- 229910052758 niobium Inorganic materials 0.000 description 2
- ZKATWMILCYLAPD-UHFFFAOYSA-N niobium pentoxide Chemical compound O=[Nb](=O)O[Nb](=O)=O ZKATWMILCYLAPD-UHFFFAOYSA-N 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 2
- UGZVCHWAXABBHR-UHFFFAOYSA-O pyridin-1-ium-1-carboxamide Chemical class NC(=O)[N+]1=CC=CC=C1 UGZVCHWAXABBHR-UHFFFAOYSA-O 0.000 description 2
- CZJWRCGMJPIJSJ-UHFFFAOYSA-O pyridin-1-ium-1-yl carbamate Chemical class NC(=O)O[N+]1=CC=CC=C1 CZJWRCGMJPIJSJ-UHFFFAOYSA-O 0.000 description 2
- KZUNJOHGWZRPMI-UHFFFAOYSA-N samarium atom Chemical compound [Sm] KZUNJOHGWZRPMI-UHFFFAOYSA-N 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- VGTPCRGMBIAPIM-UHFFFAOYSA-M sodium thiocyanate Chemical compound [Na+].[S-]C#N VGTPCRGMBIAPIM-UHFFFAOYSA-M 0.000 description 2
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 2
- 235000019345 sodium thiosulphate Nutrition 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 229940071240 tetrachloroaurate Drugs 0.000 description 2
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 2
- ZCUFMDLYAMJYST-UHFFFAOYSA-N thorium dioxide Chemical compound O=[Th]=O ZCUFMDLYAMJYST-UHFFFAOYSA-N 0.000 description 2
- XOLBLPGZBRYERU-UHFFFAOYSA-N tin dioxide Chemical compound O=[Sn]=O XOLBLPGZBRYERU-UHFFFAOYSA-N 0.000 description 2
- 230000004584 weight gain Effects 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- 229910052727 yttrium Inorganic materials 0.000 description 2
- JIHQDMXYYFUGFV-UHFFFAOYSA-N 1,3,5-triazine Chemical class C1=NC=NC=N1 JIHQDMXYYFUGFV-UHFFFAOYSA-N 0.000 description 1
- DSVIHYOAKPVFEH-UHFFFAOYSA-N 4-(hydroxymethyl)-4-methyl-1-phenylpyrazolidin-3-one Chemical compound N1C(=O)C(C)(CO)CN1C1=CC=CC=C1 DSVIHYOAKPVFEH-UHFFFAOYSA-N 0.000 description 1
- INVVMIXYILXINW-UHFFFAOYSA-N 5-methyl-1h-[1,2,4]triazolo[1,5-a]pyrimidin-7-one Chemical compound CC1=CC(=O)N2NC=NC2=N1 INVVMIXYILXINW-UHFFFAOYSA-N 0.000 description 1
- 229910004829 CaWO4 Inorganic materials 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 229920002085 Dialdehyde starch Polymers 0.000 description 1
- 229910052692 Dysprosium Inorganic materials 0.000 description 1
- 229910052691 Erbium Inorganic materials 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 229910052689 Holmium Inorganic materials 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- 229910002226 La2O2 Inorganic materials 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 229910004879 Na2S2O5 Inorganic materials 0.000 description 1
- 229910052779 Neodymium Inorganic materials 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 229910052777 Praseodymium Inorganic materials 0.000 description 1
- 229910021604 Rhodium(III) chloride Inorganic materials 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- PCSMJKASWLYICJ-UHFFFAOYSA-N Succinic aldehyde Chemical compound O=CCCC=O PCSMJKASWLYICJ-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 229910052769 Ytterbium Inorganic materials 0.000 description 1
- SJOOOZPMQAWAOP-UHFFFAOYSA-N [Ag].BrCl Chemical compound [Ag].BrCl SJOOOZPMQAWAOP-UHFFFAOYSA-N 0.000 description 1
- XCFIVNQHHFZRNR-UHFFFAOYSA-N [Ag].Cl[IH]Br Chemical compound [Ag].Cl[IH]Br XCFIVNQHHFZRNR-UHFFFAOYSA-N 0.000 description 1
- HOLVRJRSWZOAJU-UHFFFAOYSA-N [Ag].ICl Chemical compound [Ag].ICl HOLVRJRSWZOAJU-UHFFFAOYSA-N 0.000 description 1
- UQYAIJXMHRFODY-UHFFFAOYSA-K [Rh+3].[O-]C#N.[O-]C#N.[O-]C#N Chemical class [Rh+3].[O-]C#N.[O-]C#N.[O-]C#N UQYAIJXMHRFODY-UHFFFAOYSA-K 0.000 description 1
- BMOBNPSFPAGGJE-UHFFFAOYSA-K [Rh+3].[Se-]C#N.[Se-]C#N.[Se-]C#N Chemical class [Rh+3].[Se-]C#N.[Se-]C#N.[Se-]C#N BMOBNPSFPAGGJE-UHFFFAOYSA-K 0.000 description 1
- XJUCCGJZENLZSA-UHFFFAOYSA-M [Rh]Cl Chemical compound [Rh]Cl XJUCCGJZENLZSA-UHFFFAOYSA-M 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 150000001541 aziridines Chemical class 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- QVQLCTNNEUAWMS-UHFFFAOYSA-N barium oxide Inorganic materials [Ba]=O QVQLCTNNEUAWMS-UHFFFAOYSA-N 0.000 description 1
- LTPBRCUWZOMYOC-UHFFFAOYSA-N beryllium oxide Inorganic materials O=[Be] LTPBRCUWZOMYOC-UHFFFAOYSA-N 0.000 description 1
- 229910052792 caesium Inorganic materials 0.000 description 1
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- RYTLGWCJESCDMY-UHFFFAOYSA-N carbamimidoyl chloride Chemical class NC(Cl)=N RYTLGWCJESCDMY-UHFFFAOYSA-N 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 229910052729 chemical element Inorganic materials 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 229910052681 coesite Inorganic materials 0.000 description 1
- 229910052593 corundum Inorganic materials 0.000 description 1
- 229910052906 cristobalite Inorganic materials 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000002059 diagnostic imaging Methods 0.000 description 1
- 150000004891 diazines Chemical class 0.000 description 1
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical class C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 description 1
- KBQHZAAAGSGFKK-UHFFFAOYSA-N dysprosium atom Chemical compound [Dy] KBQHZAAAGSGFKK-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- UYAHIZSMUZPPFV-UHFFFAOYSA-N erbium Chemical compound [Er] UYAHIZSMUZPPFV-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 229910052735 hafnium Inorganic materials 0.000 description 1
- VBJZVLUMGGDVMO-UHFFFAOYSA-N hafnium atom Chemical compound [Hf] VBJZVLUMGGDVMO-UHFFFAOYSA-N 0.000 description 1
- 150000002366 halogen compounds Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- KJZYNXUDTRRSPN-UHFFFAOYSA-N holmium atom Chemical compound [Ho] KJZYNXUDTRRSPN-UHFFFAOYSA-N 0.000 description 1
- PIPZGJSEDRMUAW-VJDCAHTMSA-N hydron;methyl (1s,15r,18s,19r,20s)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate;chloride Chemical compound Cl.C1=CC=C2C(CCN3C[C@@H]4CC[C@H](O)[C@@H]([C@H]4C[C@H]33)C(=O)OC)=C3NC2=C1 PIPZGJSEDRMUAW-VJDCAHTMSA-N 0.000 description 1
- 150000002443 hydroxylamines Chemical class 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- PJXISJQVUVHSOJ-UHFFFAOYSA-N indium(III) oxide Inorganic materials [O-2].[O-2].[O-2].[In+3].[In+3] PJXISJQVUVHSOJ-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 150000002540 isothiocyanates Chemical class 0.000 description 1
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical class C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 1
- 150000002603 lanthanum Chemical class 0.000 description 1
- MRELNEQAGSRDBK-UHFFFAOYSA-N lanthanum oxide Inorganic materials [O-2].[O-2].[O-2].[La+3].[La+3] MRELNEQAGSRDBK-UHFFFAOYSA-N 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000006224 matting agent Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- QEFYFXOXNSNQGX-UHFFFAOYSA-N neodymium atom Chemical compound [Nd] QEFYFXOXNSNQGX-UHFFFAOYSA-N 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- GUCVJGMIXFAOAE-UHFFFAOYSA-N niobium atom Chemical compound [Nb] GUCVJGMIXFAOAE-UHFFFAOYSA-N 0.000 description 1
- KTUFCUMIWABKDW-UHFFFAOYSA-N oxo(oxolanthaniooxy)lanthanum Chemical compound O=[La]O[La]=O KTUFCUMIWABKDW-UHFFFAOYSA-N 0.000 description 1
- CMCWWLVWPDLCRM-UHFFFAOYSA-N phenidone Chemical compound N1C(=O)CCN1C1=CC=CC=C1 CMCWWLVWPDLCRM-UHFFFAOYSA-N 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920006267 polyester film Polymers 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- PUDIUYLPXJFUGB-UHFFFAOYSA-N praseodymium atom Chemical compound [Pr] PUDIUYLPXJFUGB-UHFFFAOYSA-N 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- KIWUVOGUEXMXSV-UHFFFAOYSA-N rhodanine Chemical compound O=C1CSC(=S)N1 KIWUVOGUEXMXSV-UHFFFAOYSA-N 0.000 description 1
- IHQLVWHNBCRJRB-UHFFFAOYSA-N rhodium(3+) triazide Chemical class [Rh+3].[N-]=[N+]=[N-].[N-]=[N+]=[N-].[N-]=[N+]=[N-] IHQLVWHNBCRJRB-UHFFFAOYSA-N 0.000 description 1
- BBCHGPOXBBSEMV-UHFFFAOYSA-K rhodium(3+);trithiocyanate Chemical class [Rh+3].[S-]C#N.[S-]C#N.[S-]C#N BBCHGPOXBBSEMV-UHFFFAOYSA-K 0.000 description 1
- SONJTKJMTWTJCT-UHFFFAOYSA-K rhodium(iii) chloride Chemical compound [Cl-].[Cl-].[Cl-].[Rh+3] SONJTKJMTWTJCT-UHFFFAOYSA-K 0.000 description 1
- 229910052701 rubidium Inorganic materials 0.000 description 1
- IGLNJRXAVVLDKE-UHFFFAOYSA-N rubidium atom Chemical compound [Rb] IGLNJRXAVVLDKE-UHFFFAOYSA-N 0.000 description 1
- 125000001824 selenocyanato group Chemical group *[Se]C#N 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 229910052682 stishovite Inorganic materials 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- IATRAKWUXMZMIY-UHFFFAOYSA-N strontium oxide Inorganic materials [O-2].[Sr+2] IATRAKWUXMZMIY-UHFFFAOYSA-N 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- PBCFLUZVCVVTBY-UHFFFAOYSA-N tantalum pentoxide Inorganic materials O=[Ta](=O)O[Ta](=O)=O PBCFLUZVCVVTBY-UHFFFAOYSA-N 0.000 description 1
- 150000003567 thiocyanates Chemical class 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- GWIKYPMLNBTJHR-UHFFFAOYSA-M thiosulfonate group Chemical group S(=S)(=O)[O-] GWIKYPMLNBTJHR-UHFFFAOYSA-M 0.000 description 1
- 150000004764 thiosulfuric acid derivatives Chemical class 0.000 description 1
- 150000003585 thioureas Chemical class 0.000 description 1
- FRNOGLGSGLTDKL-UHFFFAOYSA-N thulium atom Chemical compound [Tm] FRNOGLGSGLTDKL-UHFFFAOYSA-N 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 229910052905 tridymite Inorganic materials 0.000 description 1
- PBYZMCDFOULPGH-UHFFFAOYSA-N tungstate Chemical compound [O-][W]([O-])(=O)=O PBYZMCDFOULPGH-UHFFFAOYSA-N 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 description 1
- 229940090523 yocon Drugs 0.000 description 1
- 229910001845 yogo sapphire Inorganic materials 0.000 description 1
- NAWDYIZEMPQZHO-UHFFFAOYSA-N ytterbium Chemical compound [Yb] NAWDYIZEMPQZHO-UHFFFAOYSA-N 0.000 description 1
- 150000003746 yttrium Chemical class 0.000 description 1
- VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 description 1
- XLOMVQKBTHCTTD-UHFFFAOYSA-N zinc oxide Inorganic materials [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
- G03C5/00—Photographic processes or agents therefor; Regeneration of such processing agents
- G03C5/16—X-ray, infrared, or ultraviolet ray processes
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
- G03C1/00—Photosensitive materials
- G03C1/005—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein
- G03C1/035—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein characterised by the crystal form or composition, e.g. mixed grain
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
- G03C1/00—Photosensitive materials
- G03C1/005—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein
- G03C1/46—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein having more than one photosensitive layer
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
- G03C1/00—Photosensitive materials
- G03C1/005—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein
- G03C1/035—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein characterised by the crystal form or composition, e.g. mixed grain
- G03C2001/03517—Chloride content
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
- G03C1/00—Photosensitive materials
- G03C1/005—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein
- G03C1/035—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein characterised by the crystal form or composition, e.g. mixed grain
- G03C2001/03541—Cubic grains
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
- G03C1/00—Photosensitive materials
- G03C1/005—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein
- G03C1/035—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein characterised by the crystal form or composition, e.g. mixed grain
- G03C2001/03594—Size of the grains
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
- G03C7/00—Multicolour photographic processes or agents therefor; Regeneration of such processing agents; Photosensitive materials for multicolour processes
- G03C7/30—Colour processes using colour-coupling substances; Materials therefor; Preparing or processing such materials
- G03C7/3022—Materials with specific emulsion characteristics, e.g. thickness of the layers, silver content, shape of AgX grains
- G03C2007/3025—Silver content
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
- G03C2200/00—Details
- G03C2200/27—Gelatine content
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
- G03C2200/00—Details
- G03C2200/52—Rapid processing
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
- G03C2200/00—Details
- G03C2200/58—Sensitometric characteristics
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
- G03C5/00—Photographic processes or agents therefor; Regeneration of such processing agents
- G03C5/16—X-ray, infrared, or ultraviolet ray processes
- G03C5/17—X-ray, infrared, or ultraviolet ray processes using screens to intensify X-ray images
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
- G03C5/00—Photographic processes or agents therefor; Regeneration of such processing agents
- G03C5/26—Processes using silver-salt-containing photosensitive materials or agents therefor
Definitions
- This invention is directed to radiography in which radiation is aimed at certain regions of a subject to provide therapy treatment.
- it is directed to a radiographic portal imaging assembly containing a combination of two radiographic silver halide films and a pair of asymmetric fluorescent intensifying screens and to methods of use.
- This invention is useful in portal radiography.
- the object is to obtain an image of a patient's internal anatomy with as little X-radiation exposure as possible.
- the fastest imaging speeds are realized by mounting a dual-coated radiographic element between a pair of fluorescent intensifying screens for imagewise exposure. 5% or less of the exposing X-radiation passing through the patient is adsorbed directly by the latent image forming silver halide emulsion layers within the dual-coated radiographic element. Most of the X-radiation that participates in image formation is absorbed by phosphor particles within the fluorescent screens. This stimulates light emission that is more readily absorbed by the silver halide emulsion layers of the radiographic element.
- radiographic element constructions for medical diagnostic purposes are provided by U. S. Patent 4,425,425 (Abbott et al.) and U.S. Patent 4,425,426 (Abbott et al.), U.S. Patent 4,414,310 (Dickerson), U.S. Patent 4,803,150 (Kelly et al.), U.S. Patent 4,900,652 (Kelly et al.), U.S. Patent 5,252,442 (Tsaur et al.), and Research Disclosure, Vol. 184, August 1979, Item 18431.
- Radiation oncology is a field of radiology relating to the treatment of cancers using high energy X-radiation.
- This treatment is also known as teletherapy, using powerful, high energy X-radiation machines (often linear accelerators) to exposure the cancerous tissues (tumor).
- the goal of such treatment is to cure the patient by selectively killing the cancer while minimizing damage to surrounding healthy tissues.
- Such treatment is commonly carried out using high energy X-radiation, 4 to 25 MVp.
- the X-radiation beams are very carefully mapped for intensity and energy.
- the patient is carefully imaged using a conventional diagnostic X-radiation unit, a CT scanner, and/or an MRI scanner to accurately locate the various tissues (healthy and cancerous) in the patient.
- a dosimetrist determines where and for how long the treatment X-radiation will be directed, and predicts the radiation dose to the patient.
- the dosimetrist provides one or more custom-designed "blocks" or shields of lead around the patient's body to absorb X-radiation that would impact healthy tissues.
- portal radiography is generally the term used to describe such imaging.
- the first type of portal imaging is known as "localization” imaging in which the portal radiographic film is briefly exposed to the X-radiation passing through the patient with the lead shields removed and then with the lead shields in place. Exposure without the lead shields provides a faint image of anatomical features that can be used as orientation references near the targeted feature while the exposure with the lead shields superimposes a second image of the port area. This process insures that the lead shields are in the correct location relative to the patient's healthy tissues. Both exposures are made using a fraction of the total treatment dose, usually 1 to 4 monitor units out of a total dose of 45-150 monitor units. Thus, the patient receives less than 20 RAD's of radiation.
- the therapy treatment is carried out using a killing dose of X-radiation administered through the port.
- the patient typically receives from 50 to 300 RAD's during this treatment. Since any movement of the patient during exposure can reduce treatment effectiveness, it is important to minimize the time required to process the imaged films.
- a second, less common form of portal radiography is known as "verification" imaging to verify the location of the cell-killing exposure.
- the purpose of this imaging is to record enough anatomical information to confirm that the cell-killing exposure was properly aligned with the targeted tissue.
- the imaging film/cassette assembly is kept in place behind the patient for the full duration of the treatment. Verification films have only a single field (the lead shields are in place) and are generally imaged at intervals during the treatment regime that may last for weeks. Thus, it is important to insure that proper targeted tissue and only that tissue is exposed to the high level radiation because the levels of radiation are borderline lethal.
- the Portal imaging assemblies can be grouped into two categories.
- the first type of assemblies includes one or two metal plates and a radiographic silver halide film that is designed for direct exposure to X-radiation.
- Two such films that are commercially available are KODAK X-ray Therapy Localization (XTL) Film and KODAK X-ray Therapy Verification (XV) Film.
- XTL KODAK X-ray Therapy Localization
- XV KODAK X-ray Therapy Verification
- Each of these films is generally used with a single copper or lead plate. They have the advantage of having low contrast so that a wide range of exposure conditions can be used to produce useful images.
- the contrast of the imaged tissues is also very low. Coupled with the low contrast of the imaging system, the final image contrast is very low and difficult to read accurately.
- the second type of portal imaging assemblies includes a fluorescent intensifying screen and a silver halide radiographic film. These assemblies include one or two metal plates, one or two fluorescent intensifying screens, and a fine grain emulsion film. Because a significant amount of the film's exposure comes from the light emitted by the fluorescent screen(s), it is possible to use films that provide high contrast images. Thus, these imaging assemblies typically provide images having contrast 3.5 times higher than those direct imaging assemblies noted above do. However, the photospeed obtained with both types of assemblies is about the same.
- the imaging assemblies of the prior art present some problems. Due to their high contrast images and the variations in patient treatment dosages, patient tissue conditions (thickness), and exposing equipment, it is more difficult to obtain correct exposures. The images are either too light or too dark. Exposure can be controlled by adjusting the so-called "air gap" distance between the patient and the imaging system and the monitor setting. Unfortunately, many therapy machines used in therapy imaging (especially therapy verification imaging) do not allow for an adjustable "air gap". This is especially true for therapy verification imaging.
- This invention provides a solution to the noted problems with a radiographic imaging assembly comprising the following components:
- the ratio of the photographic speed of the first radiographic silver halide film to the photographic speed of the second radiographic silver halide film is greater than 0.15 logE.
- this invention provides a method of providing a black-and-white image comprising exposing the radiographic imaging assemblies described above, and processing the first and second radiographic silver halide films, sequentially, with a black-and-white developing composition and a fixing composition, the processing being carried out within 90 seconds, dry-to-dry.
- the present invention provides a means for providing high contrast images in portal imaging using a wide variety of therapy imaging machines under a wide variety of conditions.
- the present invention provided improved "exposure latitude” and “dynamic range” in this important field of radiology.
- all other desirable sensitometric properties are maintained and the first and second films can be rapidly processed in the same conventional processing equipment and compositions.
- the two fluorescent intensifying screens differ in photographic speed by at least 0.1 logE and are considered “asymmetric" screens.
- the two screens are also arranged "in association" with the two radiographic silver halide films. Imaging radiation can be directed first through either fluorescent intensifying screen before it reaches the first and second radiographic silver halide films.
- the ratio of the photographic speed of the first film to the second film is greater than 0.15 logE, and preferably greater than 0.3 logE.
- These films are arranged "in association" meaning that they are generally in physical contact with no significant gap between them in the imaging assembly.
- FIG. 1 is a schematic cross-sectional illustration of one embodiment of this invention comprising first and second radiographic silver halide films in a cassette holder with two fluorescent intensifying screens.
- FIG. 2 is a schematic cross-sectional illustration of another embodiment of this invention comprising first and second radiographic silver halide films, two intensifying screens, and a metal screen in a cassette holder.
- contrast indicates the average contrast derived from a characteristic curve of a radiographic film using as a first reference point (1) a density (D 1 ) of 0.25 above minimum density and as a second reference point (2) a density (D 2 ) of 2.0 above minimum density, where contrast is ⁇ D (i.e. 1.75) ⁇ ⁇ log 10 E (log 10 E 2 - log 10 E 1 ), E 1 and E 2 being the exposure levels at the reference points (1) and (2).
- “Gamma” is described as the instantaneous rate of change of a D logE sensitometric curve or the instantaneous contrast at any logE value.
- Peak gamma is the point of the sensitometric curve where the maximum gamma is achieved.
- Photographic "speed” refers to the exposure necessary to obtain a density of at least 1.0 plus D min .
- rapid access processing is employed to indicate dry-to-dry processing of a radiographic film in 45 seconds or less. That is, 45 seconds or less elapse from the time a dry imagewise exposed radiographic film enters a wet processor until it emerges as a dry fully processed film.
- the halides are named in order of ascending concentrations.
- ECD equivalent circular diameter
- COV coefficient of variation
- covering power is used to indicate 100 times the ratio of maximum density to developed silver measured in mg/dm 2 .
- dual-coated is used to define a radiographic film having silver halide emulsion layers disposed on both the front- and backsides of the support.
- the radiographic silver halide films used in the present invention are "dual-coated.”
- RAD is used to indicate a unit dose of absorbed radiation, that is energy absorption of 100 ergs per gram of tissue.
- port is used to indicate radiographic imaging, films and intensifying screens applied to megavoltage radiotherapy conducted through an opening or port in a radiation shield.
- localization refers to portal imaging that is used to locate the port in relation to the surrounding anatomy of the irradiated subject. Typically exposure times range from 1 to 10 seconds.
- the term "verification” refers to portal imaging that is used to record patient exposure through the port during radiotherapy. Typically exposure times range from 30 to 300 seconds.
- Exposure latitude refers to the width of the gamma/logE curves for which contrast values were greater than 1.5.
- dynamic range refers to the range of exposures over which useful images can be obtained (usually those having a gamma of at least 2).
- crossover refers to the percentage of light emitted by a fluorescent intensifying screen that strikes a dual-coated radiographic film and passes through its support to reach the image forming layer unit disposed on the opposite side of the support. Crossover can be determined as described in U.S. Patent 4,425,426 (Abbott et al.).
- fluorescent intensifying screen refers to a screen that absorbs X-radiation and emits light.
- a “prompt” emitting fluorescent intensifying screen will emit light immediately upon exposure to radiation while “storage” fluorescent screen can "store” the exposing X-radiation for emission at a later time when the screen is irradiated with other radiation (usually visible light).
- metal intensifying screen refers to a metal screen that absorbs MVp level X-radiation to release electrons and absorbs electrons that have been generated by X-radiation prior to reaching the screen.
- front and back refer to layers, films, or intensifying screens nearer to and farther from, respectively, the X-radiation source.
- rare earth is used to indicate chemical elements having an atomic number of 39 or 57 through 71.
- the present invention uses two radiographic silver halide films in the imaging assembly to achieve the desired advantages.
- the two films can be identical in construction or properties.
- the two films can differ in construction and properties, and preferably provide images that exhibit different contrast.
- the "first" film can be a "high contrast” radiographic silver halide film while the "second” film can be a "lower contrast” radiographic silver halide film because the contrast of images it provides is lower than that of images provided by the "first" film.
- the ratio of contrast of an image provided by the first radiographic silver halide film image to the contrast of an image provided by the second radiographic silver halide film image can be at least 1.25 and preferably at least 1.75. More preferably, this ratio is from 2 to 2.5.
- contrast can be adjusted in various radiographic silver halide films in various ways, for example by using different levels of dopants (or none at all in one film), by adjusting silver coverage, or by blending emulsions having different sensitivities.
- One skilled in the art would have the skill and knowledge to prepare first and second radiographic silver halide films that provide images having the noted contrast difference.
- the present invention uses two different ("asymmetric") radiographic silver halide films to achieve the desired advantages.
- the "first" film is considered a "high speed” radiographic silver halide film while the “second” film is considered a “lower speed” radiographic silver halide film because its photographic speed is lower than that of the "first” film.
- These two films are used in combination with two different (“asymmetric") fluorescent intensifying screens that also differ in photographic speed.
- the difference in speed between the first and second films, and the difference in speed between the first and second fluorescent intensifying screens can be the same or different.
- the radiographic silver halide films useful in this invention include a flexible support having disposed on both sides thereof, one or more photographic silver halide emulsion layers and optionally one or more non-radiation sensitive hydrophilic layer(s).
- the silver halide emulsions in the various layers can be the same or different in the first or second films, and can comprise mixtures of various silver halide emulsions in one or more of the layers.
- each first or second film has the same silver halide emulsions on both sides of the support. It is also preferred that each film have a protective overcoat (described below) over the silver halide emulsions on each side of the support.
- the support can take the form of any conventional radiographic film support that is X-radiation and light transmissive.
- Useful supports for the films of this invention can be chosen from among those described in Research Disclosure, September 1996, Item 38957 XV. Supports and Research Disclosure, Vol. 184, August 1979, Item 18431, XII. Film Supports.
- the support is preferably a transparent film support.
- the transparent film support consists of a transparent film chosen to allow direct adhesion of the hydrophilic silver halide emulsion layers or other hydrophilic layers. More commonly, the transparent film is itself hydrophobic and subbing layers are coated on the film to facilitate adhesion of the hydrophilic silver halide emulsion layers.
- the film support is either colorless or blue tinted (tinting dye being present in one or both of the support film and the subbing layers).
- At least one non-light sensitive hydrophilic layer is included with the one or more silver halide emulsion layers on each side of the film support. This layer may be called an interlayer or overcoat, or both.
- the silver halide emulsion layers comprise one or more types of silver halide grains responsive to X-radiation.
- Silver halide grain compositions particularly contemplated include those having at least 50 mol % chloride (preferably at least 70 and more preferably at least 80 mol % chloride), and up to 50 mol % bromide, based on total silver in a given emulsion layer.
- Such emulsions include silver halide grains composed of, for example, silver chloride, silver iodochloride, silver bromochloride, silver iodobromochloride, and silver bromoiodochloride. Iodide is generally limited to no more than 2 mol % (based on total silver in the emulsion layer) to facilitate more rapid processing.
- iodide is from 0.5 to 1.5 mol % (based on total silver in the emulsion layer) or eliminated entirely from the grains.
- the silver halide grains in each silver halide emulsion unit (or silver halide emulsion layers) can be the same or different, or mixtures of different types of grains.
- the silver halide grains useful in this invention can have any desirable morphology including, but not limited to, cubic, octahedral, tetradecahedral, rounded, spherical or other non-tabular morphologies, or be comprised of a mixture of two or more of such morphologies.
- the grains in each silver halide emulsion independently have cubic morphology.
- COV coefficient of variation
- the average silver halide grain size can vary within each radiographic silver halide film, and within each emulsion layer within that film.
- the average grain size in each radiographic silver halide film is independently and generally from 0.1 to 0.3 ⁇ m (preferably from 0.1 to 0.2 ⁇ m), but the average grain size can be different in the various emulsion layers.
- a variety of silver halide dopants can be used, individually and in combination, to improve contrast as well as other common properties, such as speed and reciprocity characteristics.
- a summary of conventional dopants to improve speed, reciprocity and other imaging characteristics is provided by Research Disclosure, Item 38957, cited above, Section I. Emulsion grains and their preparation, sub-section D. Grain modifying conditions and adjustments, paragraphs (3), (4), and (5).
- the emulsions used in the first radiographic silver halide film are doped with any of conventional rhodium dopants to increase the contrast and/or photographic speed.
- These dopants can be present in an amount of from 1 x 10 -5 to 5 x 10 -5 mole per mole of silver in each emulsion layer, and preferably at from 2 x 10 -5 to 4 x 10 -5 mol/mol Ag in each emulsion layer.
- the amount of rhodium dopant can be the same or different in the various emulsion layers.
- rhodium dopants are well known in the art and are described for example in U.S. Patent 3,737,313 (Rosecrants et al.), U.S. Patent 4,681,836 (Inoue et al.), and U.S. Patent 2,448,060 (Smith et al.).
- rhodium dopants include, but are not limited to, rhodium halides (such as rhodium monochloride, rhodium trichloride, diammonium aquapentachlororhodate, and rhodium ammonium chloride), rhodium cyanates ⁇ such as salts of [Rh(CN) 6 ] -3 , [RhF(CN) 5 ] -3 , [RhI 2 (CN) 4 ] -3 and [Rh(CN) 5 (SeCN)] -3 ⁇ , rhodium thiocyanates, rhodium selenocyanates, rhodium tellurocyanates, rhodium azides, and others known in the art, for example as described in Research Disclosure, Item 437013, page 1526, September 2000 and publications listed therein.
- the preferred rhodium dopant is diammonium aquapentachlororhodate. Mixtures of do
- the emulsions can be chemically sensitized by any convenient conventional technique as illustrated by Research Disclosure, Item 38957, Section IV.
- Chemical Sensitization Sulfur, selenium or gold sensitization (or any combination thereof) are specifically contemplated. Sulfur sensitization is preferred, and can be carried out using for example, thiosulfates, thiosulfonates, thiocyanates, isothiocyanates, thioethers, thioureas, cysteine or rhodanine. A combination of gold and sulfur sensitization is most preferred.
- the first and second radiographic silver halide films can also include varying amounts of appropriate spectral sensitizing dyes.
- Dyes useful for this purpose are well known and include, for example, cyanine and merocyanine dyes, including the benzimidazolocarbocyanine dyes described in U.S. Patent 5,210,014 (Anderson et al.).
- the useful amounts of such dyes are well known in the art but generally within the range of from 200 to 1000 mg/mole of silver in the emulsion layer.
- one or more silver halide emulsion layers include one or more covering power enhancing compounds adsorbed to surfaces of the silver halide grains.
- Such compounds include, but are not limited to, 5-mercapotetrazoles, dithioxotriazoles, mercapto-substituted tetraazaindenes, and others described in U.S. Patent 5,800,976 (Dickerson et al.) for the teaching of the sulfur-containing covering power enhancing compounds.
- the silver halide emulsion layers and other hydrophilic layers on both sides of the support of the first and second radiographic films generally contain conventional polymer vehicles (peptizers and binders) that include both synthetically prepared and naturally occurring colloids or polymers.
- the most preferred polymer vehicles include gelatin or gelatin derivatives alone or in combination with other vehicles.
- Conventional gelatino-vehicles and related layer features are disclosed in Research Disclosure, Item 38957, Section II. Vehicles, vehicle extenders, vehicle-like addenda and vehicle related addenda.
- the emulsions themselves can contain peptizers of the type set out in Section II, paragraph A. Gelatin and hydrophilic colloid peptizers.
- the hydrophilic colloid peptizers are also useful as binders and hence are commonly present in much higher concentrations than required to perform the peptizing function alone.
- the preferred gelatin vehicles include alkali-treated gelatin, acid-treated gelatin or gelatin derivatives (such as acetylated gelatin, deionized gelatin, oxidized gelatin and phthalated gelatin).
- Cationic starch used as a peptizer for tabular grains is described in U.S. Patent 5,620,840 (Maskasky) and U.S. Patent 5,667,955 (Maskasky). Both hydrophobic and hydrophilic synthetic polymeric vehicles can be used also.
- Such materials include, but are not limited to, polyacrylates (including polymethacrylates), polystyrenes and polyacrylamides (including polymethacrylamides).
- Dextrans can also be used. Examples of such materials are described for example in U.S. Patent 5,876,913 (Dickerson et al.).
- the silver halide emulsion layers (and other hydrophilic layers) in the first and radiographic films are generally fully hardened using one or more conventional hardeners.
- the amount of hardener in each silver halide emulsion and other hydrophilic layer is generally at least 2% and preferably at least 2.5%, based on the total dry weight of the polymer vehicle in each layer.
- Conventional hardeners can be used for this purpose, including but not limited to formaldehyde and free dialdehydes such as succinaldehyde and glutaraldehyde, blocked dialdehydes, ⁇ -diketones, active esters, sulfonate esters, active halogen compounds, s -triazines and diazines, epoxides, aziridines, active olefins having two or more active bonds, blocked active olefins, carbodiimides, isoxazolium salts unsubstituted in the 3-position, esters of 2-alkoxy-N-carboxy-dihydroquinoline, N-carbamoyl pyridinium salts, carbamoyl oxypyridinium salts, bis(amidino) ether salts, particularly bis(amidino) ether salts, surface-applied carboxyl-activating hardeners in combination with complex-forming salts, carbamoylonium
- the ratio of photographic speed of the first radiographic silver halide film to the second radiographic silver halide is at least 0.15 logE.
- the speed ratio is at least 0.3 logE.
- photographic speed can be adjusted in various radiographic silver halide films in various ways, for example by using various amounts of spectral sensitizing dyes, varying the silver halide grain size, or the use of specific dopants. In view of the teaching provided herein, one skilled in the art would have the skill and knowledge to prepare first and second radiographic silver halide films with the desired difference in photographic speed.
- the photographic speeds of the first and second radiographic silver halide films are different because of the varying amounts of appropriate spectral sensitizing dyes incorporated therein.
- Dyes useful for this purpose are well known and include, for example, cyanine and merocyanine dyes, including the benzimidazolocarbocyanine dyes described in U.S. Patent 5,210,014 (Anderson et al.). The useful amounts of such dyes are well known in the art but generally within the range of from 200 to 1000 mg/mole of silver in the emulsion layer.
- the levels of silver and polymer vehicle in each radiographic silver halide film used in the present invention are not critical except that the levels can be adjusted to provide the desired difference in contrast between the first and second radiographic silver halide films.
- the level of silver on each side of each film is at least 9 and no more than 15 mg/dm 2 .
- the total coverage of polymer vehicle on each side of each film is generally at least 30 and no more than 36 mg/dm 2 .
- the amounts of silver and polymer vehicle on the two sides of the support in each radiographic silver halide film can be the same or different. These amounts refer to dry weights.
- the first and second radiographic films generally include a surface protective overcoat on each side of the support that is typically provided for physical protection of the emulsion layers.
- Each protective overcoat can be sub-divided into two or more individual layers.
- protective overcoats can be sub-divided into surface overcoats and interlayers (between the overcoat and silver halide emulsion layers).
- the protective overcoats can contain various addenda to modify the physical properties of the overcoats. Such addenda are illustrated by Research Disclosure, Item 38957, Section IX. Coating physical property modifying addenda, A. Coating aids, B. Plasticizers and lubricants, C. Antistats, and D. Matting agents.
- Interlayers that are typically thin hydrophilic colloid layers can be used to provide a separation between the emulsion layers and the surface overcoats. It is quite common to locate some emulsion compatible types of protective overcoat addenda, such as anti-matte particles, in the interlayers.
- the overcoat on at least one side of the support can also include a blue toning dye or a tetraazaindene (such as 4-hydroxy-6-methyl-1,3,3a,7-tetraazaindene) if desired.
- the protective overcoat is generally comprised of one or more hydrophilic colloid vehicles, chosen from among the same types disclosed above in connection with the emulsion layers.
- Protective overcoats are provided to perform two basic functions. They provide a layer between the emulsion layers and the surface of the film for physical protection of the emulsion layer during handling and processing. Secondly, they provide a convenient location for the placement of addenda, particularly those that are intended to modify the physical properties of the radiographic film.
- the protective overcoats of the films of this invention can perform both these basic functions.
- the various coated layers of radiographic silver halide films used in this invention can also contain tinting dyes to modify the image tone to transmitted or reflected light. These dyes are not decolorized during processing and may be homogeneously or heterogeneously dispersed in the various layers. Preferably, such non-bleachable tinting dyes are in a silver halide emulsion layer.
- the radiographic imaging assemblies of the present invention are composed of the first and second radiographic silver halide films as described herein and first and second fluorescent intensifying screens that have different photographic speed.
- the fluorescent intensifying screens differ in speed by at least 0.1 logE, preferably by at least 0.2 logE, and more preferably by at least 0.3 logE.
- Such screens can be designed to have different speeds using well known technology including different amounts or types of phosphors, or different phosphor particle sizes.
- One skilled in the art would readily know how to design screens of different speed. The following discussion relates to fluorescent intensifying screens in general.
- Fluorescent intensifying screens are typically designed to absorb X-rays and to emit electromagnetic radiation having a wavelength greater than 300 nm. These screens can take any convenient form providing they meet all of the usual requirements for use in radiographic imaging. Examples of conventional, useful fluorescent intensifying screens are provided by Research Disclosure, Item 18431, cited above, Section IX. X-Ray Screens/Phosphors, and U.S. Patent 5,021,327 (Bunch et al.), U.S. Patent 4,994,355 (Dickerson et al.), U.S. Patent 4,997,750 (Dickerson et al.), and U.S. Patent 5,108,881 (Dickerson et al.).
- the fluorescent layer contains phosphor particles and a binder, optimally additionally containing a light scattering material, such as titania.
- any conventional or useful phosphor can be used, singly or in mixtures, in the intensifying screens used in the practice of this invention.
- useful phosphors are described in numerous references relating to fluorescent intensifying screens, including but not limited to, Research Disclosure, Vol. 184, August 1979, Item 18431, Section IX, X-ray Screens/Phosphors, and U.S. Patent 2,303,942 (Wynd et al.), U.S. Patent 3,778,615 (Luckey), U.S. Patent 4,032,471 (Luckey), U.S. Patent 4,225,653 (Brixner et al.), U.S. Patent 3,418,246 (Royce), U.S.
- Patent 3,428,247 (Yocon), U.S. Patent 3,725,704 (Buchanan et al.), U.S. Patent 2,725,704 (Swindells), U.S. Patent 3,617,743 (Rabatin), U.S. Patent 3,974,389 (Ferri et al.), U.S. Patent 3,591,516 (Rabatin), U.S. Patent 3,607,770 (Rabatin), U.S. Patent 3,666,676 (Rabatin), U.S. Patent 3,795,814 (Rabatin), U.S. Patent 4,405,691 (Yale), U.S. Patent 4,311,487 (Luckey et al.), U.S.
- Patent 4,387,141 (Patten), U.S. Patent 5,021,327 (Bunch et al.), U.S. Patent 4,865,944 (Roberts et al.), U.S. Patent 4,994,355 (Dickerson et al.), U.S. Patent 4,997,750 (Dickerson et al.), U.S. Patent 5,064,729 (Zegarski), U.S. Patent 5,108,881 (Dickerson et al.), U.S. Patent 5,250,366 (Nakajima et al.), U.S. Patent 5,871,892 (Dickerson et al.), EP-A-0 491,116 (Benzo et al.), with respect to the phosphors.
- Useful classes of phosphors include, but are not limited to, calcium tungstate (CaWO 4 ), activated or unactivated lithium stannates, niobium and/or rare earth activated or unactivated yttrium, lutetium, or gadolinium tantalates, rare earth (such as terbium, lanthanum, gadolinium, cerium, and lutetium)-activated or unactivated middle chalcogen phosphors such as rare earth oxychalcogenides and oxyhalides, and terbium-activated or unactivated lanthanum and lutetium middle chalcogen phosphors.
- CaWO 4 calcium tungstate
- activated or unactivated lithium stannates activated or unactivated lithium stannates
- rare earth such as terbium, lanthanum, gad
- Still other useful phosphors are those containing hafnium as described for example in U.S. Patent 4,988,880 (Bryan et al.), U.S. Patent 4,988,881 (Bryan et al.), U.S. Patent 4,994,205 (Bryan et al.), U.S. Patent 5,095,218 (Bryan et al.), U.S. Patent 5,112,700 (Lambert et al.), U.S. Patent 5,124,072 (Dole et al.), and U.S. Patent 5,336,893 (Smith et al.).
- M' (w-n) M" n O w X' wherein M' is at least one of the metals yttrium (Y), lanthanum (La), gadolinium (Gd), or lutetium (Lu), M" is at least one of the rare earth metals, preferably dysprosium (Dy), erbium (Er), europium (Eu), holmium (Ho), neodymium (Nd), praseodymium (Pr), samarium (Sm), tantalum (Ta), terbium (Tb), thulium (Tm), or ytterbium (Yb), X' is a middle chalcogen (S, Se, or Te) or halogen, n is 0.002 to 0.2, and w is 1 when X' is halogen or 2 when X' is a middle chalc
- Suitable phosphors are described in U.S. Patent 4,835,397 (Arakawa et al.) and U.S. Patent 5,381,015 (Dooms), and including for example divalent europium and other rare earth activated alkaline earth metal halide phosphors and rare earth element activated rare earth oxyhalide phosphors.
- the more preferred phosphors include alkaline earth metal fluorohalide prompt emitting and/or storage phosphors [particularly those containing iodide such as alkaline earth metal fluorobromoiodide storage phosphors as described in U.S. Patent 5,464,568 (Bringley et al.)].
- Another class of phosphors includes a rare earth host and are rare earth activated mixed alkaline earth metal sulfates such as europium-activated barium strontium sulfate.
- Particularly useful phosphors are those containing doped or undoped tantalum such as YTaO 4 , YTaO 4 :Nb, Y(Sr)TaO 4 , and Y(Sr)TaO 4 :Nb. These phosphors are described in U.S. Patent 4,226,653 (Brixner), U.S. Patent 5,064,729 (Zegarski), U.S. Patent 5,250,366 (Nakajima et al.), and U.S. Patent 5,626,957 (Benso et al.).
- alkaline earth metal phosphors that can be the products of firing starting materials comprising optional oxide and a combination of species characterized by the following formula (2): MFX 1-z I z uM a X a :yA: eQ:tD wherein "M” is magnesium (Mg), calcium (Ca), strontium (Sr), or barium (Ba), "F” is fluoride, “X” is chloride (Cl) or bromide (Br), "I” is iodide, M a is sodium (Na), potassium (K), rubidium (Rb), or cesium (Cs), X a is fluoride (F), chloride (Cl), bromide (Br), or iodide (I), "A” is europium (Eu), cerium (Ce), samarium (Sm), or terbium (Tb), "Q” is BeO, MgO, CaO, SrO, BaO, Zn
- Storage phosphors can also be used in the practice of this invention.
- Various storage phosphors are described for example, in U.S. Patent 5,464,568 (noted above).
- Such phosphors include divalent alkaline earth metal fluorohalide phosphors that may contain iodide are the product of firing an intermediate, comprising oxide and a combination of species characterized by the following formula (3): (Ba 1-a-b-c Mg a Ca b Sr c )FX 1-z I z rM a X a :yA wherein X, M a , X a , A, z, and y have the same meanings as for formula (2) and the sum of a, b, and c is from 0 to 4, and r is from 10 -6 to 0.1.
- Some embodiments of these phosphors are described in more detail in U.S. Patent 5,464,568 (noted above).
- Still other storage phosphors are described in U.S. Patent 4,368,390 (Takahashi et al.), and include divalent europium and other rare earth activated alkaline earth metal halides and rare earth element activated rare earth oxyhalides, as described in more detail above.
- Examples of useful phosphors include: SrS:Ce,SM, SrS:Eu,Sm, ThO 2 :Er, La 2 O 2 S:Eu,Sm, ZnS:Cu,Pb, and others described in U.S. Patent 5,227,253 (Takasu et al.).
- a variety of such screens are commercially available from several sources including by not limited to, LANEXTM, X-SIGHTTM and InSightTM Skeletal screens available from Eastman Kodak Company.
- FIGURES 1 and 2 Two embodiments of the present invention are illustrated in FIGURES 1 and 2.
- first radiographic silver halide film 20 is arranged in association with second radiographic silver halide film 30 in cassette holder 40 , along with fluorescent intensifying screens 50 and 60 , the first being in the "front" of imaging assembly 10 and the other being in the "back".
- FIG. 2 also shows the presence of metal intensifying screen 70 in the front of fluorescent intensifying screen 50 .
- Front and back screens can be appropriately arranged in the imaging assembly in any suitable manner.
- the optimal results are achieved by arranging the higher speed fluorescent intensifying screen in front of the higher speed radiographic silver halide film, and the lower speed fluorescent intensifying screen in back of the lower speed radiographic silver halide film.
- the preferred arrangement would be as follows, in the order in which exposing X-radiation passes through:
- a metal intensifying screen is used, it is preferably located in front of the higher speed fluorescent intensifying screen.
- the metal intensifying screens can also be used in the practice of this invention, or included within the radiographic imaging assemblies of the invention.
- Metal intensifying screens can also take any convenient conventional form. While the metal intensifying screens can be formed of many different types of materials, the use of metals is most common, since metals are most easily fabricated as thin foils, often mounted on radiation transparent backings to facilitate handling. Convenient metals for screen fabrication are in the atomic number range of from 22 (titanium) to 82 (lead). Metals such as copper, lead, tungsten, iron and tantalum have been most commonly used for screen fabrication with lead and copper in that order being the most commonly employed metals. Generally the higher the atomic number, the higher the density of the metal and the greater its ability to absorb MVp X-radiation.
- Exposure and processing of the first and second radiographic silver halide films can be undertaken in any convenient conventional manner.
- the exposure and processing techniques of U.S. Patent 5,021,327 and U.S. Patent 5,576,156 are typical for processing radiographic films.
- Other processing compositions are described in U.S. Patent 5,738,979 (Fitterman et al.), U.S. Patent 5,866,309 (Fitterman et al.), U.S. Patent 5,871,890 (Fitterman et al.), U.S. Patent 5,935,770 (Fitterman et al.), U.S. Patent 5,942,378 (Fitterman et al.).
- the processing compositions can be supplied as single- or multi-part formulations, and in concentrated form or as more diluted working strength solutions.
- both first and second radiographic silver halide films can be similarly processed, and preferably processed using the same processing compositions and conditions.
- the first and second radiographic silver halide films be processed within 90 seconds ("dry-to-dry") and preferably within 45 seconds and at least 20 seconds, for the developing, fixing and any washing (or rinsing) steps.
- processing can be carried out in any suitable processing equipment including but not limited to, a Kodak X-OMATTM RA 480 processor that can utilize Kodak Rapid Access processing chemistry.
- Kodak X-OMATTM RA 480 processor that can utilize Kodak Rapid Access processing chemistry.
- Other "rapid access processors" are described for example in U.S. Patent 3,545,971 (Barnes et al) and EP-A-0 248,390 (Akio et al).
- the black-and-white developing compositions used during processing are free of any gelatin hardeners, such as glutaraldehyde.
- the preferred radiographic films satisfying the requirements of the present invention are specifically identified as those that are capable of dry-to-dye processing according to the following reference conditions: Development 11.1 seconds at 35°C, Fixing 9.4 seconds at 35°C, Washing 7.6 seconds at 35°C, Drying 12.2 seconds at 55-65°C. Any additional time is taken up in transport between processing steps.
- Typical black-and-white developing and fixing compositions are described in the Example below.
- Radiographic kits of the present invention can include a radiographic imaging assembly of this invention, one or more metal screens, and/or one or more suitable processing compositions (for example black-and-white developing and fixing compositions).
- the kit includes all of these components.
- X-radiation typically of from about 4 to about 25 MVp, is directed at a region of the subject (that is, patient) containing features to be identified by different levels of X-radiation absorption.
- This exposed region is generally somewhat larger than the radiotherapy target area for the purpose of obtaining a discernible image of anatomy reference features outside the targeted area.
- a first image is created in the one of the radiographic films (for example, the first radiographic film) as the X-radiation penetrates the subject.
- a shield containing a port is generally placed between the subject and the source of X-radiation, and X-radiation is again directed at the subject, this time through the portal, thereby creating a second image through the port that is superimposed on the first image in the first exposed radiographic film.
- the total exposure during these steps A and B for localization imaging is generally limited to 10 seconds or less.
- the first and second radiographic films, the first and second fluorescent intensifying screens, and optional metal screens can be assembled and used in a cassette as is well known in the art.
- Radiographic Film A
- Radiographic Film A is a high contrast film. It was a dual coated film having the same silver halide emulsion on both sides of a blue-tinted 178 ⁇ m transparent poly(ethylene terephthalate) film support. The emulsions were chemically sensitized with sodium thiosulfate, potassium tetrachloroaurate, sodium thiocyanate, and potassium selenocyanate and spectrally sensitized with 350 mg/mole of Ag with the S-1 dye shown below.
- Radiographic Film A had the following layer arrangement on each side of the film support:
- Overcoat Formulation Coverage (mg/dm 2 ) Gelatin vehicle 3.4 Methyl methacrylate matte beads 0.14 Carboxymethyl casein 0.57 Colloidal silica (LUDOX AM) 0.57 Polyacrylamide 0.57 Chrome alum 0.025 Resorcinol 0.058 Whale oil lubricant 0.15 Interlayer Formulation Coverage (mg/dm 2 ) Gelatin vehicle 3.4 Carboxymethyl casein 0.57 Colloidal silica (LUDOX AM) 0.57 Polyacrylamide 0.57 Chrome alum 0.025 Resorcinol 0.058 Nitron 0.044 Emulsion Layer Formulation Coverage (mg/dm 2 ) Cubic grain emulsion [AgClBr (70:30 halide ratio) 0.25 ⁇ m average size] 11.5 Diammonium aquapentachlororhodate 3.89 x 10 -5 mol/Ag mole Spectral sensitizing dye S-1 (shown below) 350 mg/Ag mole Ge
- Radiographic Film B
- Radiographic Film B was commercially available KODAK X-ray Therapy Localization (XTL) Film used in radiation therapy imaging.
- XTL X-ray Therapy Localization
- Radiographic Film C
- Radiographic Film C is a "lower contrast" film that had the following layer arrangement and formulations on both sides of the film support:
- the cassettes used in the practice of this invention were those commonly used in localization imaging. It comprised a 1 mm thick copper front metal screen and two fluorescent intensifying screens, one in the front and the other in the back of the two radiographic silver halide films.
- Screen “W” is a commercially available LANEX Fast back fluorescent intensifying screen. It comprised a terbium activated gadolinium oxysulfite phosphor having a medium particle size was 7 ⁇ m and dispersed in a PERMUTHANE polyurethane binder (phosphor at 13.3 g/dm 2 , 19:1 phosphor to binder ratio) on a white pigmented polyester support.
- Screen “X” is a commercially available LANEX MinR Medium fluorescent intensifying screen. It comprised a terbium activated gadolinium oxysulfide phosphor having a medium particle size of 5-6 ⁇ m and dispersed in a PERMUTHANE polyurethane binder (phosphor at 3.1 g/dm 2 , 19:1 phosphor to binder ratio) on a white pigmented polyester support.
- PERMUTHANE polyurethane binder phosphor at 3.1 g/dm 2 , 19:1 phosphor to binder ratio
- Screen “Y” is commercially available LANEX Regular general purpose fluorescent intensifying screen. It comprised a terbium activated gadolinium oxysulfide phosphor having a medium particle size of 7 ⁇ m and dispersed in a PERMUTHANE polyurethane binder (phosphor at 7 g/dm 2 , 15:1 phosphor to binder ratio) on a white pigmented polyester support.
- a terbium activated gadolinium oxysulfide phosphor having a medium particle size of 7 ⁇ m and dispersed in a PERMUTHANE polyurethane binder (phosphor at 7 g/dm 2 , 15:1 phosphor to binder ratio) on a white pigmented polyester support.
- the photographic speed of the various fluorescent intensifying screens are as follows: Screen W is 180 speed, Screen X is 40 speed, and Screen Y is 100 speed wherein Screen 100 has been arbitrarily assigned a photographic speed (light emission) of 100 for 6 MVp X-radiation exposure.
- Radiographic Films A, B, and C were exposed using an inverse square X-ray sensitometer.
- This is a device that makes exceedingly reproducible exposures.
- a lead screw moves the detector between exposures.
- distances are selected that produce exposures that differ by 0.100 logE.
- the length of the exposures is a constant. With this instrument, we can obtain sensitometry that gives the response of the detector to an imagewise exposure. The image is exposed for the same length of time but the intensity changes due to the anatomy transmitting more or less of the X-radiation flux.
- the inverse square X-ray sensitometer was set to make-exposures at 100 kVp with 0.5 mm of copper and 1 mm aluminum added filtration. While this is not the same energy created by a radiation therapy treatment machine, it is suitable for demonstrating that one can control exposure latitude while maintaining excellent image contrast.
- the film samples were in contact with the developer in each instance for less than 90 seconds. Fixing was carried out using KODAK RP X-OMAT LO Fixer and Replenisher fixing composition (Eastman Kodak Company).
- Rapid processing has evolved over the last several years as a way to increase productivity in busy hospitals without compromising image quality or sensitometric response. Where 90-second processing times were once the standard, below 40-second processing is becoming the standard in medical radiography.
- RA KODAK Rapid Access
- One such example of a rapid processing system is the commercially available KODAK Rapid Access (RA) processing system that includes a line of X-radiation sensitive films available as T-MAT-RA radiographic films that feature fully forehardened emulsions in order to maximize film diffusion rates and minimize film drying. Processing chemistry for this process is also available.
- glutaraldehyde a common hardening agent
- the developer and fixer designed for this system are Kodak X-OMAT RA/30 chemicals.
- a commercially available processor that allows for the rapid access capability is the Kodak X-OMAT RA 480 processor.
- This processor is capable of running in 4 different processing cycles. "Extended” cycle is for 160 seconds, and is used for mammography where longer than normal processing results in higher speed and contrast.
- "Standard” cycle is 82 seconds, "Rapid Cycle” is 55 seconds and "KWIK/RA” cycle is 40 seconds (see KODAK KWIK Developer below).
- the KWIK cycle uses the RA/30 processing compositions while the longer time cycles use standard commercially available RP X-OMAT compositions.
- Table I shows typical processing times (seconds) for these various processing cycles. Cycle Extended Standard Rapid KWIK Black-and-white Development 44.9 27.6 15.1 11.1 Fixing 37.5 18.3 12.9 9.4 Washing 30.1 15.5 10.4 7.6 Drying 47.5 21.0 16.6 12.2 Total 160.0 82.4
- the black-and-white developing composition useful for the KODAK KWIK cycle contains the following components: Hydroquinone 32 g 4-Hydroxymethyl-4-methyl-1-phenyl-3-pyrazolidone 6 g Potassium bromide 2.25 g 5-Methylbenzotriazole 0.125 g Sodium sulfite 160 g Water to 1 liter, pH 10.35
- Optical densities are expressed below in terms of diffuse density as measured by a conventional X-rite Model 310TM densitometer that was calibrated to ANSI standard PH 2.19 and was traceable to a National Bureau of Standards calibration step tablet.
- the characteristic D vs. logE curve was plotted for each radiographic film that was imaged and processed.
- Speed was measured at a density of 1.4 + D min .
- Gamma (contrast) is the slope of the noted curves. The results are shown in TABLE II below.
- the "% Drying" was determined by feeding an exposed film flashed to result in a density of 1.0 into an X-ray processing machine in the KODAK KWIK cycle. As the film just exits the drier section, the processing machine was stopped and the film was removed. Roller marks from the processing machine can be seen on the film where the film has not yet dried. Marks from 100% of the rollers in the drier indicate the film has just barely dried. Values less than 100% indicate the film was dried partway into the drier. The lower the value the better the film is for drying. Film Relative Speed Contrast Image Quality Drying KWIK Cycle A 100 5.6 Excellent 50% B 100 1.6 Good 100% C 100 2.6 Good 50%
- Film A provided excellent image quality as a result of very high contrast. It also dried very quickly in the ultra-rapid KODAK KWIK cycle processing. However, due to the high contrast, it does not have much exposure latitude and is difficult to use when therapy machines of fixed film/focal length are used or when exposure settings are not sufficiently fine enough to get the proper exposure.
- Film B provided reasonable image quality and exposure but cannot be processed in the KODAK KWIK cycle process.
- Film C provided good image quality and acceptable exposure latitude and was processable in the KODAK KWIK cycle processing.
- the results of exposure latitude (gamma > 2.0 in units of logE) and dynamic range (relative to direct Film B) with individual or combinations of films, and the combination of first and second films, with first and second fluorescent intensifying screens according to the present invention are shown in TABLE III below.
- Radiographic Film D was a dual coated film having the same silver halide emulsion on both sides of a blue-tinted 178 ⁇ m transparent poly(ethylene terephthalate) film support.
- the emulsions were chemically sensitized with sodium thiosulfate, potassium tetrachloroaurate, sodium thiocyanate and potassium selenocyanate.
- Radiographic Film D had the following layer arrangement on each side of the film support:
- Overcoat Formulation Coverage (mg/dm 2 ) Gelatin vehicle 3.4 Methyl methacrylate matte beads 0.14 Carboxymethyl casein 0.57 Colloidal silica (LUDOX AM) 0.57 Polyacrylamide 0.57 Chrome alum 0.025 Resorcinol 0.058 Whale oil lubricant 0.15 Interlayer Formulation Coverage (mg/dm 2 ) Gelatin vehicle 3.4 Carboxymethyl casein 0.57 Colloidal silica (LUDOX AM) 0.57 Polyacrylamide 0.57 Chrome alum 0.025 Resorcinol 0.058 Nitron 0.044 Emulsion Layer Formulation Coverage (mg/dm 2 ) Cubic grain emulsion: [AgClBr (70:30 halide ratio) 0.25 ⁇ m average size] 11.5 Spectral sensitizing dye S-1 (shown below) 350 mg/Ag mole Diammonium aquapentachlororhodate 3.89 x 10 -5 mol/Ag mole
- Radiographic Film B
- Radiographic Film B was commercially available KODAK X-ray Therapy Localization (XTL) Film used in radiation therapy localization imaging.
- XTL KODAK X-ray Therapy Localization
- Radiographic Film C
- Radiographic Film C had the following layer arrangement and formulations on both sides of the film support. Its emulsions were chemically sensitized as described for Film D.
- Radiographic Film E
- Film E was identical to Film C except that it contained 500 mg/Ag mole of the spectral sensitizing dye S-1.
- the cassettes used in the practice of this invention were those commonly used in localization imaging. It comprised a 1 mm thick copper front metal screen and two fluorescent intensifying screens, one in the front and the other in the back of the two radiographic silver halide films.
- Screen “W” is a commercially available LANEX Fast back fluorescent intensifying screen, as described in Example 1.
- Screen “X” is a commercially available LANEX MinR Medium fluorescent intensifying screen, as described in Example 1.
- Screen “Y” is commercially available LANEX Regular general purpose fluorescent intensifying screen, as described in Example 1.
- the photographic speed of the various fluorescent intensifying screens are as follows: Screen W is 180 speed, Screen X is 40 speed, and Screen Y is 100 speed wherein Screen Y was arbitrarily assigned a photographic speed of 100 for 6 MVp X-radiation exposure.
- the inverse square X-ray sensitometer was set to make exposures at 100 kVp with 0.5 mm of copper and 1 mm aluminum added filtration. While this is not the same energy created by a radiation therapy treatment machine, it is suitable for demonstrating that one can control exposure latitude while maintaining excellent image contrast.
- the film samples were in contact with the developer in each instance for less than 90 seconds. Fixing was carried out using KODAK RP X-OMAT LO Fixer and Replenisher fixing composition (Eastman Kodak Company).
- Rapid processing has evolved over the last several years as a way to increase productivity in busy hospitals without compromising image quality or sensitometric response. Where 90-second processing times were once the standard, below 40-second processing is becoming the standard in medical radiography.
- RA KODAK Rapid Access
- One such example of a rapid processing system is the commercially available KODAK Rapid Access (RA) processing system that includes a line of X-radiation sensitive films available as T-MAT-RA radiographic films that feature fully forehardened emulsions in order to maximize film diffusion rates and minimize film drying. Processing chemistry for this process is also available.
- glutaraldehyde a common hardening agent
- the developer and fixer designed for this system are Kodak X-OMAT RA/30 chemicals.
- a commercially available processor that allows for the rapid access capability is the Kodak X-OMAT RA 480 processor.
- This processor is capable of running in 4 different processing cycles. "Extended” cycle is for 160 seconds, and is used for mammography where longer than normal processing results in higher speed and contrast.
- "Standard” cycle is 82 seconds, "Rapid Cycle” is 55 seconds and "KWIK/RA” cycle is 40 seconds (see KODAK KWIK Developer below).
- the KWIK cycle uses the RA/30 processing compositions while the longer time cycles use standard commercially available RP X-OMAT compositions. Table I above shows typical processing times (seconds) for these various processing cycles.
- Optical densities are expressed below in terms of diffuse density as measured by a conventional X-rite Model 310TM densitometer that was calibrated to ANSI standard PH 2.19 and was traceable to a National Bureau of Standards calibration step tablet.
- the characteristic D vs. logE curve was plotted for each radiographic film that was imaged and processed. Photographic speed was measured at a density of 1.4 + D min .
- Gamma (contrast) is the slope of the noted curves. The results are shown in TABLE IV below.
- the "% Drying" was determined by feeding an exposed film flashed to result in a density of 1.0 into an X-ray processing machine in the KODAK KWIK cycle. As the film just exits the drier section, the processing machine was stopped and the film was removed. Roller marks from the processing machine can be seen on the film where the film has not yet dried. Marks from 100% of the rollers in the drier indicate the film has just barely dried. Values less than 100% indicate the film was dried partway into the drier. The lower the value the better the film is for drying. Film Relative Speed Contrast Image Quality Drying KWIK Cycle D 100 5.6 Excellent 50% B 100 1.6 Good 100% C 100 2.6 Good 50% E 50 3.1 Good 50%
- Film D provided excellent image quality as a result of very high contrast. It also dried very quickly in the ultra-rapid KODAK KWIK cycle processing. However, due to the high contrast, it does not have much exposure latitude and is difficult to use when therapy machines of fixed film/focal length are used or when exposure settings are not sufficiently fine enough to get the proper exposure.
- Film B provided reasonable image quality and exposure but cannot be processed in the KODAK KWIK cycle process.
- Films C and E provided good image quality, wide exposure latitude, and were processable in the KODAK KWIK cycle processing.
- the results of exposure latitude (gamma > 2.0 in units of logE) and dynamic range (relative to direct Film B) with individual films and combinations of first and second radiographic films are shown in TABLE V below.
Landscapes
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Silver Salt Photography Or Processing Solution Therefor (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US893595 | 2001-06-28 | ||
US09/894,767 US6489077B1 (en) | 2001-06-28 | 2001-06-28 | Portal imaging assembly with pair of asymmetric screens and method of use |
US894767 | 2001-06-28 | ||
US09/893,595 US6485879B1 (en) | 2001-06-28 | 2001-06-28 | Portal imaging assembly with asymmetric films and asymmetric screens and method of use |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1271239A2 true EP1271239A2 (de) | 2003-01-02 |
EP1271239A3 EP1271239A3 (de) | 2003-02-12 |
Family
ID=27129058
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02077431A Withdrawn EP1271239A3 (de) | 2001-06-28 | 2002-06-19 | Anordnung zur Portalbilderzeugung mit asymmetrischen Verstärkerschirmen und Verfahren zur Verwendung |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP1271239A3 (de) |
JP (1) | JP2003066552A (de) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2528671C2 (ru) * | 2008-07-23 | 2014-09-20 | Конинклейке Филипс Электроникс Н.В. | Cd2O2S МАТЕРИАЛ ДЛЯ ИСПОЛЬЗОВАНИЯ В КОМПЬЮТЕРНОЙ ТОМОГРАФИИ |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3737313A (en) | 1971-06-17 | 1973-06-05 | Eastman Kodak Co | Paper radiographic element containing silver halide grains rhodium salt sensitized,thioether ripened and polyvalent metal ion stabilized |
US4414310A (en) | 1981-11-12 | 1983-11-08 | Eastman Kodak Company | Process for the preparation of high aspect ratio silver bromoiodide emulsions |
US4425426A (en) | 1982-09-30 | 1984-01-10 | Eastman Kodak Company | Radiographic elements exhibiting reduced crossover |
US4425425A (en) | 1981-11-12 | 1984-01-10 | Eastman Kodak Company | Radiographic elements exhibiting reduced crossover |
US4803150A (en) | 1986-12-23 | 1989-02-07 | Eastman Kodak Company | Radiographic element exhibiting reduced crossover |
US4900652A (en) | 1987-07-13 | 1990-02-13 | Eastman Kodak Company | Radiographic element |
US5252442A (en) | 1991-05-14 | 1993-10-12 | Eastman Kodak Company | Radiographic elements with improved detective quantum efficiencies |
US5871892A (en) | 1996-02-12 | 1999-02-16 | Eastman Kodak Company | Portal radiographic imaging |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE530129A (de) * | ||||
NL56131C (de) * | 1940-09-02 | |||
DE1019173B (de) * | 1955-05-14 | 1957-11-07 | Siemens Reiniger Werke Ag | Aus strahlungsempfindlichen und Verstaerkerschichten bestehende Anordnung zur gleichzeitigen Herstellung mehrerer fotografischer Aufnahmen in nur einem Belichtungsprozess |
CA2074898A1 (en) * | 1991-08-16 | 1993-02-17 | Eastman Kodak Company | Minimal crossover radiographic elements adapted for flesh and bone imaging |
IT1255402B (it) * | 1992-07-02 | 1995-10-31 | Struttura radiografica con ridotto cross-over a guisa di immagine e trattabilita' rapidissima | |
US5952147A (en) * | 1998-04-29 | 1999-09-14 | Eastman Kodak Company | Portal verification radiographic element and method of imaging |
-
2002
- 2002-06-19 EP EP02077431A patent/EP1271239A3/de not_active Withdrawn
- 2002-06-28 JP JP2002190315A patent/JP2003066552A/ja active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3737313A (en) | 1971-06-17 | 1973-06-05 | Eastman Kodak Co | Paper radiographic element containing silver halide grains rhodium salt sensitized,thioether ripened and polyvalent metal ion stabilized |
US4414310A (en) | 1981-11-12 | 1983-11-08 | Eastman Kodak Company | Process for the preparation of high aspect ratio silver bromoiodide emulsions |
US4425425A (en) | 1981-11-12 | 1984-01-10 | Eastman Kodak Company | Radiographic elements exhibiting reduced crossover |
US4425426A (en) | 1982-09-30 | 1984-01-10 | Eastman Kodak Company | Radiographic elements exhibiting reduced crossover |
US4425426B1 (de) | 1982-09-30 | 1988-08-09 | ||
US4803150A (en) | 1986-12-23 | 1989-02-07 | Eastman Kodak Company | Radiographic element exhibiting reduced crossover |
US4900652A (en) | 1987-07-13 | 1990-02-13 | Eastman Kodak Company | Radiographic element |
US5252442A (en) | 1991-05-14 | 1993-10-12 | Eastman Kodak Company | Radiographic elements with improved detective quantum efficiencies |
US5871892A (en) | 1996-02-12 | 1999-02-16 | Eastman Kodak Company | Portal radiographic imaging |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2528671C2 (ru) * | 2008-07-23 | 2014-09-20 | Конинклейке Филипс Электроникс Н.В. | Cd2O2S МАТЕРИАЛ ДЛЯ ИСПОЛЬЗОВАНИЯ В КОМПЬЮТЕРНОЙ ТОМОГРАФИИ |
Also Published As
Publication number | Publication date |
---|---|
EP1271239A3 (de) | 2003-02-12 |
JP2003066552A (ja) | 2003-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4865944A (en) | Unitary intensifying screen and radiographic element | |
US6457860B1 (en) | Light-weight imaging assemblies for oncology portal imaging | |
EP1422561B1 (de) | Radiographische Bildaufzeichnungskombination für die Mammographie | |
US7005226B2 (en) | High speed imaging assembly for radiography | |
US6489077B1 (en) | Portal imaging assembly with pair of asymmetric screens and method of use | |
US6485879B1 (en) | Portal imaging assembly with asymmetric films and asymmetric screens and method of use | |
US20020155373A1 (en) | Radiation oncology treatment portal imaging film and method of use | |
US6485880B1 (en) | Portal imaging assembly with laminated neutral density filter and method of use | |
US6489076B1 (en) | Portal imaging assembly with magenta filter and method of use | |
US6482563B1 (en) | Portal imaging assembly with neutral density filter and method of use | |
EP1271239A2 (de) | Anordnung zur Portalbilderzeugung mit asymmetrischen Verstärkerschirmen und Verfahren zur Verwendung | |
EP1213606B1 (de) | Bildaufzeichnungsmaterial zur Ermittlung des zu behandelnden Körperteils, das in der Bestrahlung von Tumoren verwendet wird, und Verwendungsmethode | |
US6828077B2 (en) | Mammography imaging method using high peak voltage | |
US7147982B2 (en) | Ultrahigh speed imaging assembly for radiography | |
EP1271238A2 (de) | Anordnung zur Portalbilderzeugung mit Neutraldichte-Filter und Verfahren zur Verwendung | |
US6485881B1 (en) | Asymmetric speed portal imaging assembly and method of use | |
US7018770B1 (en) | High speed reflective radiographic material | |
US6582874B1 (en) | Radiation oncology treatment portal imaging film and method of use | |
US6485882B1 (en) | Asymmetric contrast portal imaging assembly and method of use | |
US6887641B2 (en) | Mammography imaging method using high peak voltage and rhodium or tungsten anodes | |
US6864045B2 (en) | Mammography film and imaging assembly for use with rhodium or tungsten anodes | |
EP1422557B1 (de) | Mammographischer Film und Bildaufzeichnungskombination zur Verwendung mit Rhodium- oder Wolframanoden | |
EP1385049B1 (de) | Asymmetrischer radiographischer Film zur Mammographie und Verfahren für dessen Entwicklung | |
US20050100837A1 (en) | Ultrahigh speed imaging assembly for orthopedic radiography |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
AK | Designated contracting states |
Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
17P | Request for examination filed |
Effective date: 20030716 |
|
AKX | Designation fees paid |
Designated state(s): BE DE FR IT |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20070103 |